Twitter | Search | |
Daniel Stover, MD
Breast cancer doctor & translational researcher. Clinical computational oncology All views my own
1,470
Tweets
963
Following
1,968
Followers
Tweets
Daniel Stover, MD retweeted
The James Jun 12
Vaccination could be a major part of the future of treatment—and is playing a major role in the research. Listen to our latest Cancer-Free World Podcast, as Dr. Robert Wesolowski provides the details of personalized cancer vaccines.
Reply Retweet Like
Daniel Stover, MD Jun 13
Niraparib (PARPi) + pembro for metastatic : -Of 55pts, 10 with complete/partial response -49% disease control rate. -Most benefit was in BRCAmut patients Congrats to the authors
Reply Retweet Like
Daniel Stover, MD Jun 13
Congrats ! Such an important resource/ontology.
Reply Retweet Like
Daniel Stover, MD Jun 13
Hey - Both lead authors of this paper are LRP recipients! We both truly appreciate the support!
Reply Retweet Like
Daniel Stover, MD retweeted
Gad Getz Laboratory Jun 7
Congrats to Dr. Keren Yizhak and collabs! Our comprehensive analysis (29 normal tissues/~500 individuals) shows that most healthy tissues contain genetic clones with .
Reply Retweet Like
Daniel Stover, MD retweeted
Danielle Ofri Jun 9
I just have to share this image again because it is diagnostic of what is wrong in US today. (If that top line were , the US might have a fighting chance at getting itself out of last place for health outcomes....)
Reply Retweet Like
Daniel Stover, MD retweeted
Hal Burstein, MD Jun 8
Superb piece. Must reading for busy clinicians and those who claim to care about leadership in medicine
Reply Retweet Like
Daniel Stover, MD Jun 8
Look at those two! - is there ‘interventional CardioOncology’ so we can get to join the onc world?!
Reply Retweet Like
Daniel Stover, MD retweeted
Catherine Carson Jun 8
My family and I were privileged to join so many in stepping up for Stefanie today!
Reply Retweet Like
Daniel Stover, MD Jun 8
Reply Retweet Like
Daniel Stover, MD Jun 8
Step Up for Stefananie’s Champions today! -Celebrating champions -Remembering Stefanie Spielman’s incredible legacy -Raises $$ to support amazing work by to tackle breast cancer Thanks to everyone who makes this possible!
Reply Retweet Like
Daniel Stover, MD retweeted
Aleix Prat Jun 7
Today our multidisciplinary team reports the first evidence that BRCA1 somatic mutations might predict PARP1 inhibitor benefit in breast cancer
Reply Retweet Like
Daniel Stover, MD Jun 6
Welcome to Twitter !
Reply Retweet Like
Daniel Stover, MD Jun 5
Replying to @tmprowell @ASCO and 2 others
Yes! And of course!
Reply Retweet Like
Daniel Stover, MD Jun 5
Got home from to find a picture of some guy who looks VERY familiar (w a solid bow tie game) in Daily News. Thanks to everyone who made amazing and looking forward to led by !
Reply Retweet Like
Daniel Stover, MD Jun 5
Congratulations, ! Excited for you and ! You are going to be an amazing PI.
Reply Retweet Like
Daniel Stover, MD Jun 4
Replying to @ProfNoto
Congratulations Noto!!
Reply Retweet Like
Daniel Stover, MD Jun 3
Sadly, I am headed to the airport. Next time!
Reply Retweet Like
Daniel Stover, MD retweeted
Nicole Kuderer Jun 3
TBCRC 030 ph II RCT of neodj cisplatin (C) vs pacli (T) in —Evaluating HRD biomarker “In this mostly BRCA1/2 proficient TNBC cohort, baseline HRD was not predictive of response to preoperative platinum CT, defined either by RCB 0-1 or pCR.”
Reply Retweet Like
Daniel Stover, MD retweeted
Nicole Kuderer Jun 3
ph II RCT neodj pacli/olaparib (PwO) vs pacli/carbo (PwCb) followed by epi/cyclo in HRD positive pts: pCR rate not inferior with PwO 55.1% vs PwCb 48.6% *Subgroups provocative results: 🔺pCR w PwO in pts < 40 years and HR+ pts (needs confirmation)
Reply Retweet Like